These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evolution of the bioavailability and other pharmacokinetic parameters of levodopa (with carbidopa) in rabbits. Fernandez N, Prieto C, Sierra M, Diez MJ, Sahagun A, Gonzalez A, Garcia JJ. Methods Find Exp Clin Pharmacol; 2008 Mar; 30(6):451-7. PubMed ID: 18850046 [Abstract] [Full Text] [Related]
3. Clinical Metabolomics to Segregate Aromatic Amino Acid Decarboxylase Deficiency From Drug-Induced Metabolite Elevations. Pappan KL, Kennedy AD, Magoulas PL, Hanchard NA, Sun Q, Elsea SH. Pediatr Neurol; 2017 Oct; 75():66-72. PubMed ID: 28823629 [Abstract] [Full Text] [Related]
4. L-dopa-resistant Parkinsonism due to dopa decarboxylase deficiency? Jankovic J. Ann Neurol; 1981 Jul; 10(1):64-5. PubMed ID: 7271235 [No Abstract] [Full Text] [Related]
5. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa. Med Lett Drugs Ther; 2005 Jan 31; 47(1201):12. PubMed ID: 15706700 [Abstract] [Full Text] [Related]
6. Aromatic L-amino acid decarboxylase: conformational change in the flexible region around Arg334 is required during the transaldimination process. Ishii S, Hayashi H, Okamoto A, Kagamiyama H. Protein Sci; 1998 Aug 31; 7(8):1802-10. PubMed ID: 10082378 [Abstract] [Full Text] [Related]
7. Unusually mild phenotype of AADC deficiency in 2 siblings. Tay SK, Poh KS, Hyland K, Pang YW, Ong HT, Low PS, Goh DL. Mol Genet Metab; 2007 Aug 31; 91(4):374-8. PubMed ID: 17533144 [Abstract] [Full Text] [Related]
10. A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease. Nausieda PA, Pfeiffer RF, Tagliati M, Kastenholz KV, DeRoche C, Slevin JT. Clin Ther; 2005 Jan 15; 27(1):58-63. PubMed ID: 15763606 [Abstract] [Full Text] [Related]
11. Aromatic L-amino acid decarboxylase deficiency with hyperdopaminuria. Clinical and laboratory findings in response to different therapies. Fiumara A, Bräutigam C, Hyland K, Sharma R, Lagae L, Stoltenborg B, Hoffmann GF, Jaeken J, Wevers RA. Neuropediatrics; 2002 Aug 15; 33(4):203-8. PubMed ID: 12368991 [Abstract] [Full Text] [Related]
12. Clinical and biochemical characterization of patients with early infantile onset of autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia. Opladen T, Hoffmann G, Hörster F, Hinz AB, Neidhardt K, Klein C, Wolf N. Mov Disord; 2011 Jan 15; 26(1):157-61. PubMed ID: 20818608 [Abstract] [Full Text] [Related]
13. Aromatic L-amino acid decarboxylase deficiency in Taiwan. Lee HF, Tsai CR, Chi CS, Chang TM, Lee HJ. Eur J Paediatr Neurol; 2009 Mar 15; 13(2):135-40. PubMed ID: 18567514 [Abstract] [Full Text] [Related]
15. Familial dopa-responsive cervical dystonia. Schneider SA, Mohire MD, Trender-Gerhard I, Asmus F, Sweeney M, Davis M, Gasser T, Wood NW, Bhatia KP. Neurology; 2006 Feb 28; 66(4):599-601. PubMed ID: 16505323 [Abstract] [Full Text] [Related]
16. Efficacy of levodopa and carbidopa on visual function in patients with non-arteritic anterior ischaemic optic neuropathy. Simsek T, Eryilmaz T, Acaroglu G. Int J Clin Pract; 2005 Mar 28; 59(3):287-90. PubMed ID: 15857324 [Abstract] [Full Text] [Related]
17. Deletion in the tyrosine hydroxylase gene in a patient with a mild phenotype. Ormazabal A, Serrano M, Garcia-Cazorla A, Campistol J, Artuch R, Castro de Castro P, Barredo-Valderrama E, Armstrong J, Toma C, Cormand B. Mov Disord; 2011 Jul 28; 26(8):1558-60. PubMed ID: 21465550 [No Abstract] [Full Text] [Related]